. . "# de Paulis T: ONO-2506. Ono. Curr Opin Investig Drugs. 2003 Jul;4(7):863-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14619409 # Manev R, Manev H: Could treatment with arundic acid (ONO-2506) increase vulnerability for depression? Med Hypotheses. 2006;67(5):1170-2. Epub 2006 Jun 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16797859"@en . . . "Investigated for use/treatment in cerebral ischemia."@en . . . . "ONO-2506"@en . . . . . "ONO-2506 is an enantiomeric, three carbon atom homolog of valproic acid under development by ONO Pharmaceutical for the potential treatment of stroke, as well as Alzheimer's and Parkinson's disease."@en . . "investigational"@en . . . . . . . . . . . . "ONO-256 is a neuroprotective because of its actions on glia cells. It has inhibitory effects on the synthesis of a calcium-binding protein S100B. ONO-2506 is undergoing clinical trials for the treatment of patients with stroke and Alzheimer's disease."@en . . . . . . . .